(Q79613933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Matthias Eberl

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Marina Zafranskaya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Patrick Oschmann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Rosel Engel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Andreas Weishaupt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Hassan Jomaa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

18 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

29-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

IFN-beta treatment modulates the CD28/CTLA-4-mediated pathway for IL-2 production in patients with relapsing-remitting multiple sclerosis

24 December 2019

cites work

1 reference

12 December 2020

Escalating immunotherapy of multiple sclerosis--new aspects and practical application.

1 reference

12 December 2020

IFNbeta-1a treatment and reestablishment of Th1 regulation in MS patients: dose effects

1 reference

12 December 2020

Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysis.

1 reference

12 December 2020

Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.

1 reference

12 December 2020

Cross-presentation by intercellular peptide transfer through gap junctions.

1 reference

12 December 2020

Type I interferons (alpha/beta) in immunity and autoimmunity

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

1 reference

12 December 2020

Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease

1 reference

12 December 2020

Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice

1 reference

12 December 2020

B lymphocytes participate in cross-presentation of antigen following gene gun vaccination

1 reference

12 December 2020

The role of CD8(+) T cells in multiple sclerosis and its animal models

1 reference

12 December 2020

Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis--novel insights and new therapeutic strategies

1 reference

12 December 2020

A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells

1 reference

12 December 2020

Professional antigen-presentation function by human gammadelta T Cells

1 reference

12 December 2020

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?

1 reference

12 December 2020

The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis

1 reference

12 December 2020

Immunomodulatory effects of IFN-beta1a treatment alone or associated with pentoxifylline in patients with relapsing-remitting multiple sclerosis (RRMS).

1 reference

12 December 2020

Association between peripheral IFN-γ producing CD8+ T-cells and disability score in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

IL-2 is required for the activation of memory CD8+ T cells via antigen cross-presentation

1 reference

12 December 2020

Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.

1 reference

12 December 2020

Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory

1 reference

12 December 2020

Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis

1 reference

12 December 2020

Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production

1 reference

12 December 2020

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

12 December 2020

Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4

1 reference

12 December 2020

T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls

1 reference

12 December 2020

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

12 December 2020

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

1 reference

12 December 2020

Degeneracy, as opposed to specificity, in immunotherapy

1 reference

12 December 2020

New concepts in the immunopathogenesis of multiple sclerosis

1 reference

12 December 2020

The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study

1 reference

12 December 2020

Differentiation of human gamma-delta T cells towards distinct memory phenotypes

1 reference

12 December 2020

Interferon gamma and interleukin 4 producing T cells in peripheral blood of multiple sclerosis patients undergoing immunomodulatory treatment

1 reference

12 December 2020

Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study

1 reference

12 December 2020

Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls

1 reference

12 December 2020

Systemic IFN-beta treatment induces apoptosis of peripheral immune cells in MS patients

1 reference

12 December 2020

A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis

1 reference

12 December 2020

Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients

1 reference

12 December 2020

Serial Analysis of Soluble Intercellular Adhesion Molecule-1 Level in Relapsing-Remitting Multiple Sclerosis Patients During IFN-β1b Treatment

1 reference

12 December 2020

Cutting edge: cross-presentation as a mechanism for efficient recruitment of tumor-specific CTL to the brain.

1 reference

12 December 2020

A sensitive method for detecting proliferation of rare autoantigen-specific human T cells

1 reference

12 December 2020

Immune tolerance to myelin proteins.

1 reference

12 December 2020

Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis.

1 reference

12 December 2020

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

1 reference

12 December 2020

Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis

1 reference

12 December 2020

Autoreactive T cells in healthy individuals

1 reference

12 December 2020

High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay

1 reference

12 December 2020

Cellular mechanisms governing cross-presentation of exogenous antigens

1 reference

12 December 2020

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

1 reference

12 December 2020

Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro

1 reference

12 December 2020

Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

1 reference

12 December 2020

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

12 December 2020

Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro.

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

12 December 2020

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

1 reference

12 December 2020

Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein

1 reference

12 December 2020

Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones

1 reference

12 December 2020

Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides

1 reference

12 December 2020

Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).

1 reference

12 December 2020

Interferon-beta interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes

1 reference

12 December 2020

Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis

1 reference

12 December 2020

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

1 reference

12 December 2020

Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients

1 reference

12 December 2020

Immunological effects of in vivo interferon-beta1b treatment in ten patients with multiple sclerosis: a 1-year follow-up

1 reference

12 December 2020

What do we know about the mechanism of action of disease-modifying treatments in MS?

1 reference

12 December 2020

10.1111/J.1365-2567.2006.02518.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17239199%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference